About this trial
* Epidemiology \& Impact Thoracic trauma is a common and serious injury worldwide-especially in developing countries-and carries high rates of morbidity and mortality. Complications arise primarily from hypoventilation, which leads to atelectasis, pneumonia, and respiratory failure. * Key to Reducing Complications: Pain Control Effective analgesia is the cornerstone of preventing respiratory complications. Inadequate pain relief causes patients to splint and hypoventilate, setting the stage for pulmonary collapse and infection. * Conservative Management * Analgesics: Systemic pharmacological pain relief remains the mainstay. * Supportive Measures: Rest, application of ice, and encouragement of deep breathing exercises. * Incentive Spirometry: Promoted in all patients to maintain lung expansion and ward off atelectasis. * Regional Anesthesia Techniques
To further improve comfort and respiratory mechanics, ultrasound-guided nerve blocks are employed according to fracture location:
* Serratus Anterior Plane Block for anterolateral rib fractures * Thoracic Paravertebral Block for posterior rib fractures * Surgical Intervention Reserved for complex cases-such as flail chest or fractures with risk of organ injury-where stabilization or repair may be necessary. * Identified Gap Despite these options, thoracic surgeons currently lack a standardized, procedure-specific pain management protocol beyond systemic analgesics, highlighting a need for consensus guidelines that integrate pharmacological and regional techniques.
Eligibility criteria
This trial does not accept healthy volunteersQualifiers
All trauma adult patient (18-70 years) with multiple fracture ribs
Disqualifiers
Patient with multiple fracture rib with anterior flail segment
Significant head trauma
Trial design
Parallel
Treatments tested in this trial
Nerve block with Lidocain
Procedure/SurgeryInjection of Lidocaine (7mg/kg) with Epinephrine 1:100000 under Ultrasonographical guidance
pharmacological analgesics
DrugOral Paracetamol (500mg/6hr), IV Ketolac (15mg/6hr) and IV perfelgan (1gm/6hr)
Treatment groups
Trial outcomes
Primary outcomes
Improvement in patients pain score (neumerical score)
Secondary outcomes
improving intercostal tube duration in days
improving total hospital stay in days
improving patient satisfaction (questionnaire)
Locations
Sponsors and contacts
Click on the lead sponsor to view all of their trials.
This trial is not recruiting at the moment. You can still explore other options: